The present invention relates to a pharmaceutical composition, for human and veterinary use, that may be used to induce, potentiate and normalise the various phases of the tissue repair process triggered following ulceration and wounding—either involving the loss of matter or not—of neurogenic, vasogenic or traumatic origin, even in cases where the lesions are directly or indirectly associated with underlying systemic pathologies.Particularly, the present invention relates to a pharmaceutical composition comprising an N-acyl derivative of an amino alcohol belonging to the ALIAmides class of molecules, a polyhydroxy alcohol and trans-traumatic acid or a derivative thereof.
